NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

A long time ago I dug deep into pre-approval manufacturing gearing up to commercialization. It was my conclusion back then that regulators make a special effort before approval to make the new technologies companies understandably implement prior to approval, gearing up for approval, easier to get approved. Further, having the ability to potentially meet demand and create a treatment that is validly not just efficacious but deliverable, is a consideration for the regulators.

So at that time it was my conclusion that they would likely delay until they had gotten their commercialization and specifically their manufacturing technologies to a certain point in the regulatory process before applying to any regulator.

I am sure they would have loved to have had more availability for patients sooner. But there is only so much that can be done at any given time. The obvious solution has always been to have many more resources but the objective of all of the shorting has always been to keep them short on resources and maximize dilution. In that context, the shorts have been successful. But shorts cannot change the technology.